Orally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety. [electronic resource]
Producer: 20110602Description: 559-64 p. digitalISSN:- 1536-0210
- Abdomen -- diagnostic imaging
- Administration, Oral
- Adult
- Antioxidants -- administration & dosage
- Ascorbic Acid -- administration & dosage
- Biomarkers
- Contrast Media -- administration & dosage
- Cross-Over Studies
- Drug Therapy, Combination
- Humans
- Intestine, Large -- diagnostic imaging
- Liver -- diagnostic imaging
- Male
- Manganese -- administration & dosage
- Radionuclide Imaging
- Statistics as Topic
- Time Factors
- Trace Elements -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.